Aurora Cannabis Inc. (ACB) Financial Ratios
20 years of historical data (2007–2026) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
N/A
—
5yr avg: 5.98
30Y Low6.0·High6.0
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.46
+9% vs avg
5yr avg: 0.42
30Y Low0.4·High8.3
ROE
↑
-21.8%
↓+66% vs avg
5yr avg: -65.0%
30Y Low-365%·High8%
Debt/EBITDA
N/A
—
5yr avg: 3.78
30Y Low3.8·High3.8
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ACB Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Aurora Cannabis Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $181M | $185M | $245M | $225M | $225M | $284M | $1.5B | $1.2B | $7.5B | $3.3B | $466M |
| Enterprise Value | $119M | $97M | $164M | $145M | $150M | $209M | $1.5B | $1.6B | $7.9B | $3.4B | $370M |
| P/E Ratio → | -1.93 | — | 154.04 | — | — | — | — | — | — | 47.13 | — |
| P/S Ratio | 0.80 | 0.58 | 0.71 | 0.83 | 1.01 | 1.28 | 6.23 | 4.47 | 30.62 | 60.37 | 25.78 |
| P/B Ratio | 0.46 | 0.36 | 0.40 | 0.37 | 0.43 | 0.54 | 0.75 | 0.57 | 1.71 | 2.13 | 2.12 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | 15.29 | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ACB EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.30 | 0.48 | 0.54 | 0.67 | 0.95 | 6.07 | 5.84 | 32.36 | 62.43 | 20.45 |
| EV / EBITDA | — | — | 5.98 | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | 5.71 | — | — | — | — | — | — | 38.68 | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
ACB Profitability
Margins and return-on-capital ratios measuring operating efficiency
Aurora Cannabis Inc. earns an operating margin of -50.8%. Operating margins have compressed from -17.2% to -50.8% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -21.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 5.2% | 5.2% | 54.6% | 48.6% | 6.6% | 9.6% | -8.8% | -7.4% | 58.0% | 78.8% | 88.9% |
| Operating Margin | -50.8% | -50.8% | 1.4% | -17.2% | -92.6% | -104.6% | -115.3% | -173.3% | -129.6% | -173.5% | -61.9% |
| Net Profit Margin | -38.0% | -38.0% | 0.5% | -25.6% | -364.9% | -776.0% | -282.8% | -1221.7% | -119.5% | 130.3% | -71.8% |
Return on Capital
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -21.8% | -21.8% | 0.3% | -12.3% | -156.5% | -134.4% | -33.4% | -100.7% | -9.8% | 8.1% | -11.5% |
| ROA | -16.8% | -16.8% | 0.2% | -7.8% | -88.2% | -94.2% | -24.6% | -76.7% | -7.8% | 6.5% | -7.6% |
| ROIC | -25.8% | -25.8% | 0.7% | -7.2% | -34.7% | -14.2% | -9.5% | -9.6% | -7.3% | -8.0% | -12.0% |
| ROCE | -25.6% | -25.6% | 0.7% | -6.6% | -30.1% | -14.1% | -10.8% | -11.9% | -9.1% | -9.0% | -7.2% |
ACB Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $113M exceeds total debt of $24M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.05 | 0.17 | 0.17 | 0.43 | 0.43 | 0.20 | 0.25 | 0.15 | 0.13 | 0.29 |
| Debt / EBITDA | — | — | 3.78 | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.17 | -0.13 | -0.13 | -0.14 | -0.14 | -0.02 | 0.17 | 0.10 | 0.07 | -0.44 |
| Net Debt / EBITDA | — | — | -2.92 | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -89.99 | -89.99 | 3.42 | -3.20 | -4.75 | -22.95 | -9.53 | -42.88 | -7.39 | 7.57 | -12.36 |
Net cash position: cash ($113M) exceeds total debt ($24M)
ACB Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Aurora Cannabis Inc.'s current ratio of 5.94x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 3.32x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 3.42x to 5.94x over the past 3 years.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.94 | 5.94 | 4.31 | 3.42 | 2.02 | 2.02 | 5.72 | 1.53 | 1.51 | 2.92 | 8.25 |
| Quick Ratio | 3.32 | 3.32 | 2.16 | 1.93 | 1.48 | 1.48 | 4.54 | 0.97 | 1.14 | 2.35 | 7.75 |
| Cash Ratio | 2.46 | 2.46 | 1.68 | 1.47 | 1.27 | 1.27 | 3.82 | 0.62 | 0.83 | 1.99 | 7.44 |
| Asset Turnover | — | 0.53 | 0.40 | 0.32 | 0.24 | 0.24 | 0.09 | 0.09 | 0.04 | 0.03 | 0.06 |
| Inventory Turnover | 1.74 | 1.74 | 0.65 | 0.74 | 1.62 | 1.55 | 1.94 | 1.88 | 0.63 | 0.27 | 0.17 |
| Days Sales Outstanding | — | 50.75 | 44.90 | 61.43 | 67.43 | 68.18 | 83.63 | 73.19 | 167.62 | 100.51 | 46.87 |
ACB Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Aurora Cannabis Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 0.6% | — | — | — | — | — | — | 2.1% | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $57M | $56M | $51M | $32M | $21M | $17M | $10M | $8M | $4M | $2M |
Peer Comparison
Compare ACB with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ACBYou | $181M | -1.9 | — | — | 5.2% | -50.8% | -21.8% | -25.8% | — |
 CGC | $372M | -1.6 | — | — | 24.5% | -56.8% | -61.9% | -18.2% | — |
 TLRY | $551M | -0.1 | — | — | 29.3% | -277.9% | -89.1% | -66.2% | — |
 CRON | $1B | -110.6 | — | 6679.1 | 32.5% | -1.5% | -0.8% | -0.7% | — |
 OGI | $136M | -9.8 | — | — | 3.7% | -34.1% | -5.4% | -17.8% | — |
 SMG | $4B | 26.2 | 14.1 | 13.7 | 30.6% | 10.5% | — | 13.3% | 5.5 |
 IIPR | $2B | 15.2 | 10.3 | 9.7 | 88.7% | 46.7% | 6.0% | 4.3% | 2.0 |
 HYFM | $4M | -0.0 | — | — | 1.6% | -29.4% | -361.3% | -12.9% | — |
 LWAY | $389M | 28.6 | 19.0 | — | 27.4% | 7.6% | 17.6% | 17.8% | 0.0 |
 MAPS | $67M | 21.5 | 1.1 | 5.0 | 87.3% | 6.7% | 1.6% | 9.1% | 1.0 |
 SNDL | $368M | -33.6 | 8.1 | 9.0 | 27.3% | -0.5% | -1.4% | -0.3% | 3.3 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 20 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
ACB — Frequently Asked Questions
Quick answers to the most common questions about buying ACB stock.
What is Aurora Cannabis Inc.'s P/E ratio?
Aurora Cannabis Inc.'s current P/E ratio is -1.9x. The historical average is 100.6x.
What is Aurora Cannabis Inc.'s ROE?
Aurora Cannabis Inc.'s return on equity (ROE) is -21.8%. The historical average is -55.4%.
Is ACB stock overvalued?
Based on historical data, Aurora Cannabis Inc. is trading at a P/E of -1.9x. Compare with industry peers and growth rates for a complete picture.
What are Aurora Cannabis Inc.'s profit margins?
Aurora Cannabis Inc. has 5.2% gross margin and -50.8% operating margin.